Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
Status:
Completed
Trial end date:
2017-08-22
Target enrollment:
Participant gender:
Summary
The current study aims to evaluate the safety of SP-8203, designing in two stages (stage-1,
stage-2) to evaluate the safety and efficacy of the combination therapy of SP-8203 and rtPA
for the occurrence of cerebral hemorrhage in patients with acute ischemic stroke receiving
rtPA standard of care.